Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-22-001314

← back to feed
Filed
Aug 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jun 30, 2022 50.72M sh
Capex Q2 2022 · Jun 30, 2022 $0
Capex Q2 2022 · Jun 30, 2021 $0
Stockholders Equity Q2 2022 · Jun 30, 2022 −$190.77K
Stockholders Equity Q2 2022 · Dec 31, 2021 −$171.26K
Total Liabilities Q2 2022 · Jun 30, 2022 $212.89K
Total Liabilities Q2 2022 · Dec 31, 2021 $196.48K
Total Assets Q2 2022 · Jun 30, 2022 $19.54K
Total Assets Q2 2022 · Dec 31, 2021 $22.63K
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2021 $0
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$236.72K
Sga Expense Q2 2022 · Jun 30, 2021 $152.16K
Sga Expense Q2 2022 · Jun 30, 2021 $314.85K
Operating Income Q2 2022 · Jun 30, 2021 −$152.16K
Operating Income Q2 2022 · Jun 30, 2021 −$314.85K